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INTRODUCTION
Incontinentia pigmenti (IP; MIM308300), also known as Bloch-Sulzberger syndrome, is an X-linked dominant disorder, with variable dermatological, ocular, skeletal, dental and neurological manifestations. 1 Rarely, cleft lip and palate can also occur. 2 Affected males almost always die prenatally, but cells expressing the mutated X chromosome are eliminated selectively around the time of birth, and thus females with IP usually survive and exhibit extremely skewed X-inactivation. Clinically, the prominent cutaneous signs of IP occur in four classic phases: perinatal inflammatory erythema, vesicles and pustules, followed by verrucous papules and hyperkeratosis, and then hyperpigmentation, and subsequently, skin pallor, dermal atrophy and scarring. 3 In 2000, the International Incontinentia Pigmenti Consortium demonstrated that IP results from mutations in NEMO, encoding NF-kappa-B essential modulator (NF-B), which later became known as inhibitor of nuclear factor kappa-B kinase subunit gamma (IKK-) with the gene referred to as IKBKG. 4 The role of IKK- is to regulate NF-B activation of several genes involved in inflammation and cell survival, and thus in IP the lack of active NF-B makes cells more prone to apoptosis. 4 The most common pathogenic mutation in IKBKG in patients with IP is a large intragenic deletion that removes exons 4-10, inclusive. 5 This single mutation accounts for ~80% of the total molecular pathology of IP and thus accurate methods to detect it are vital for disease diagnostics. Technically, this is not straightforward as there is a non-functional copy of IKBKG running in the opposite direction, 6 which may also show deletions with no phenotypic consequences, and thus new polymerase chain reaction (PCR) primer protocols have been developed, 6 and then further modified, 7 to address this potential concern. Although the newer protocols allow for both internal controls and false negatives, 7 there remains some bias in PCR amplification for the wild-type over the deletion mutant allele, which we address in this report. We also present the clinical features and molecular pathology of IP in a Filipino family with 5 affected members.
4

CASE
The proband is a 24-day-old girl born at full term to unrelated parents. Full details of the pedigree are shown in Fig. 1a (the proband is individual III-5). Clinically, there were linear streaks of vesicles following Blaschko's lines, on the trunk, back and extremities but which spared the face, palms and soles (Fig. 1b) . Bilateral clefting abnormalities affecting the lip and extending to the nose and palate were noted. A patch of hair loss was also seen on the scalp vertex. The rest of the physical examinations were unremarkable. Her mother (now aged 31 years) and an older sister (Fig. 2a) . To determine whether the pathogenic mutation in IKBKG was the most frequently observed large intragenic deletion, we developed a modified version of a published protocol, 7 using the three primers detailed in that paper, but changing the buffer and amplification conditions because the existing protocol favours amplification of the wild-type allele because of large differences in the GC content of the PCR products: the 733-bp fragment (internal control) has a 56% GC content, whereas the 1045-bp deletion fragment has a 62% GC content. Presence of the deletion by PCR was demonstrated in the proband as well as the affected sister and mother (Fig. 2b) and was confirmed in the proband's DNA using L2Rev to Sanger sequence the 1045-bp fragment (Fig. 2c) . Full details of the new recommended PCR protocol are presented in Figure 2d .
Most cases of IP are sporadic, with new mutations usually being paternal rather than maternal in origin. 8 Familial IP occurs in up to 25% of cases, with reports of up to four generations manifesting IP. 9 With regard to genotype-phenotype correlation, there is widespread clinical heterogeneity even within those individuals whose IP results from the recurrent IKBKG deletion, findings which reflect variable patterns and degrees of Xinactivation. Indeed, only the proband in this study has central facial abnormalities. Of most phenotypic concern in IP are potential central nervous system abnormalities, which can include developmental delay, seizures, hemiplegia, hemiparesis, spasticity, microcephaly and cerebellar ataxia. 10 None of these, however, manifested in any individuals in this Filipino family. There is also cleft lip and palate and alopecia affecting the scalp vertex. 
